Document Detail


Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?
MedLine Citation:
PMID:  17078002     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intestinal glutamine utilization is integral to mucosal regeneration. We analyzed the systemic and intestinal glutamine status in Crohn's disease (CD) and evaluated the therapeutic effect of glutamine supplementation in an animal model of ileitis. In CD, glutamine concentrations were decreased systemically and in noninflamed and inflamed ileal/colonic mucosa. Mucosal glutaminase activities were depressed in the ileum independent of inflammation but were not different from controls in the colon. In experimental ileitis, oral glutamine feeding prevented macroscopic inflammation, enhanced ileal and colonic glutaminase activities above controls, and normalized the intestinal glutathione redox status. However, glutamine supplementation enhanced myeloperoxidase activity along the gastrointestinal tract and potentiated lipid peroxidation in the colon. In conclusion, glutamine metabolism is impaired in CD. In experimental ileitis, glutamine supplementation prevents inflammatory tissue damage. In the colon, however, which does not use glutamine as its principal energy source, immune enhancement of inflammatory cells by glutamine increases oxidative tissue injury.
Authors:
Bernd Sido; Cornelia Seel; Achim Hochlehnert; Raoul Breitkreutz; Wulf Dröge
Publication Detail:
Type:  Evaluation Studies; Journal Article     Date:  2006-11-01
Journal Detail:
Title:  Digestive diseases and sciences     Volume:  51     ISSN:  0163-2116     ISO Abbreviation:  Dig. Dis. Sci.     Publication Date:  2006 Dec 
Date Detail:
Created Date:  2007-01-01     Completed Date:  2007-02-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902782     Medline TA:  Dig Dis Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2170-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Ruprecht-Karls University, Heidelberg, Germany. bernd_sido@med.uni-heidelberg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Case-Control Studies
Colon / metabolism*,  pathology
Crohn Disease / diet therapy*,  metabolism*,  pathology
Dietary Supplements
Disease Models, Animal
Enteral Nutrition
Female
Glutaminase / metabolism*
Glutamine / administration & dosage,  metabolism*,  therapeutic use*
Glutathione / metabolism
Humans
Ileitis / chemically induced,  diet therapy
Ileum / metabolism*,  pathology
Indomethacin
Intestinal Mucosa / metabolism,  pathology
Lipid Peroxidation
Male
Middle Aged
Rats
Rats, Sprague-Dawley
Rectus Abdominis / metabolism,  pathology
Chemical
Reg. No./Substance:
53-86-1/Indomethacin; 56-85-9/Glutamine; 70-18-8/Glutathione; EC 3.5.1.2/Glutaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of a specific cyclooxygenase-gene polymorphism (A-842G/C50T) on the occurrence of peptic ulce...
Next Document:  Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric can...